 outcome of death, stroke, and nonfatal myocardial infarction was very imprecise (RR0.52; 95% CI 0.20 to 1.33) due to
the small number of patients (323) and events (18). All the
events were in the SAPHIRE trial whereas Brooks et al did not

JOURNAL OF VASCULAR SURGERY
Volume 48, Number 2

